Beijing-based Sinovac Biotech Ltd (NASDAQ:SVA) has developed a COVID-19 vaccine. This vaccine was injected into rhesus macaques, and the first animal trial has proven very effective against SARS-CoV-2.
Animal study demonstrated that a purified inactivated COVID-19 vaccine candidate could develop novel coronavirus neutralizing antibodies in rats, mice, and non-human primates (rhesus macaques).
Moreover, clinical studies with vaccine candidate, including other COVID-19 vaccine candidates, are expected to begin later this year.
There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.
Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.
As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.